Abstract

A sensitive, fast, and reproducible high performance thin-layer chromatographic method has been developed for simultaneous analysis of diosgenin and quercetin from fenugreek seeds, using TLC aluminium plates precoated with silica gel G60F254. Among the different combinations of mobile phases used, best separation was achieved in Toluene-ethyl acetate-formic acid (5 : 4 : 1, v/v/v). Densitometric scanning of the plates directly at 275nm was used for analysis of quercetin. While as for analysis of diosgenin, plates were scanned at 450nm after spraying with anisaldehyde-sulphuric acid reagent. The retardation factorvalue of diosgenin and quercetin was found to be 0.69 ± 0.02 and 0.57 ± 0.02, respectively. The method was validated for specificity, precision (intraday and interday), accuracy, and robustness. Accuracy of the method was checked by recovery study of three different levels with the average percentage recovery of 99.13 ± 0.26 for diosgenin and 99.63 ± 0.34 for quercetin, respectively. Dried fenugreek seed samples were found to contain diosgenin in the range of 0.113–0.135% (w/w) and quercetin in the range of 0.009–0.012% (w/w). The present method is being reported for the first time and can be used for routine quality control and quantification of these marker compounds in various plant samples, extracts, and market formulations.

Highlights

  • Research literature survey suggests pharmacological properties of fenugreek seed are attributed to presence of specific bioactive compounds like steroidal diosgenin, alkaloid trigonelline, flavonoid quercetin, galactomannan, and unusual amino acid 4-hydroxyisoleucine [7]

  • Diosgenin and quercetin are very important bioactive constituents of fenugreek seeds; there is an urgent need to develop a simple method for simultaneous estimation of these two chemotherapeutic compounds using sophisticated instruments like high performance liquid chromatography (HPLC) and (HPTLC)

  • The plates were directly scanned within 10 minutes using densitometric scanner III with WinCATS software (Camag) in the UV mode with the deuterium source set at 275 nm

Read more

Summary

Introduction

Research literature survey suggests pharmacological properties of fenugreek seed are attributed to presence of specific bioactive compounds like steroidal diosgenin, alkaloid trigonelline, flavonoid quercetin, galactomannan, and unusual amino acid 4-hydroxyisoleucine [7]. Among these above mentioned key bioactive compounds of fenugreek, diosgenin, and quercetin (Figure 1), have been reported to be of utmost importance and are known to produce desired. Diosgenin and quercetin are very important bioactive constituents of fenugreek seeds; there is an urgent need to develop a simple method for simultaneous estimation of these two chemotherapeutic compounds using sophisticated instruments like high performance liquid chromatography (HPLC) and (HPTLC). The method is being reported for the first time and can widely be applied for routine analysis and quality assurance of related extracts, drugs, and polyherbal formulations

Experimental
Validation of Method
Results and Discussion
Conclusion
Conflict of Interests
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call